Modafinil and the risk of cardiovascular events: Findings from three US claims databases.

Sigal Kaplan Earl L GoehringSigal Melamed-GalBao-Anh Nguyen-KhoaHelena KnebelJudith K Jones

Published in: Pharmacoepidemiology and drug safety (2018)

Except for few CV outcomes, applying one common protocol generated consistent risk estimates of CV events following modafinil use across cohorts and databases.

Keyphrases

cardiovascular events
coronary artery disease
cardiovascular disease
big data
health insurance
randomized controlled trial
type diabetes
machine learning
insulin resistance
glycemic control